This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chlorophenyl group and a pyrrolidine ring, makes it a valuable building block for developing drugs targeting the central nervous system (CNS). It is particularly relevant in the creation of compounds that interact with neurotransmitter receptors, such as dopamine or serotonin receptors, which are critical in treating psychiatric and neurological disorders like depression, anxiety, and schizophrenia. Additionally, its unique chemical framework allows for modifications that enhance drug efficacy and selectivity, making it a key component in medicinal chemistry research and drug development pipelines.